School is about to start. How will NY handle COVID, monkeypox, polio risks?
With schools starting in just a couple weeks, the state is rolling out overhauled COVID-19 policies that ease quarantine and...
Vaccines
Guest post: What happened when we tried to get a paper claiming ‘billions of lives are potentially at risk’ from COVID-19 vaccines retracted
In February, the editor-in-chief of Food and Chemical Toxicology published an editorial calling for “Papers on potential toxic effects of...
Pfizer-BioNTech COVID booster targeting omicron BA.5 under FDA review
Pfizer and German partner BioNTech have submitted their new COVID-19 booster – that targets the omicron subvariant BA.5 – to the...
Overlapping emergencies strain the nation’s public health workforce and threaten critical vaccination campaigns
Health officials are banking on vaccinations to contain monkeypox and polio before those become standing threats in the United States....
Free COVID-19 Vaccines for Americans Could End by Fall, Prices Are Likely To Go Up
Saving Money / Health peterschreiber.media / Getty Images/iStockphoto The days of the government providing free COVID-19 vaccines are coming to...
Pfizer asks FDA to authorize Covid booster shots that target omicron BA.5 for people ages 12 and older
In this photo illustration, vials and a medical syringe seen in front of the Food and Drug Administration (FDA) of...
Pfizer and BioNTech seek FDA authorization for updated Covid-19 booster
This updated formulation will combine the original vaccine with one that targets Omicron sublineages BA.4 and BA.5, and would be...
Anthony Fauci, face of coronavirus response, to retire in December
Anthony S. Fauci, the nation’s preeminent infectious-disease expert who achieved unprecedented fame while enduring withering political attacks as the face...
What will insurance coverage of COVID-19 vaccines and treatments look like? The Biden administration is trying to figure that out
© Getty Images CORONAVIRUS UPDATE Get ready for a big change in how the U.S. will pay for COVID-19 vaccines...
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Adolescents Aged 12 Through 17
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S. Doses of the Novavax COVID-19 Vaccine, Adjuvanted are...